Valneva SE (VALN) Assets Average (2022 - 2026)

Valneva SE's (VALN) quarterly Assets Average came in at $449.9 million in Q1 2026, down 13.61% year-on-year from $520.8 million in Q1 2025, and down 8.95% quarter-over-quarter from $494.1 million in Q4 2025.

Valneva SE (VALN) Assets Average (2022 - 2026) Analysis & Trends

Valneva SE has disclosed Assets Average across 5 years of filings, most recently posting $449.9 million for Q1 2026.

  • Assets Average for Q1 2026 came in at $449.9 million, down 13.61% year-over-year; the trailing twelve-month figure through Mar 2026 was $449.9 million (down 13.61% YoY), and the FY2025 annual result was $499.3 million, down 2.99% from the prior year.
  • Assets Average came in at $449.9 million for Q1 2026 at Valneva SE, down from $494.1 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $903.9 million in Q1 2022 to a low of $449.9 million in Q1 2026.
  • The 5-year median for Assets Average is $534.9 million (2024), against an average of $596.3 million.
  • Across the five-year window, Assets Average declined 29.91% in 2023 and rose 3.77% in 2024, its largest moves.
  • Valneva SE's Assets Average stood at $668.9 million in 2022, then retreated by 20.64% to $530.8 million in 2023, then increased by 3.77% to $550.8 million in 2024, then declined by 10.3% to $494.1 million in 2025, then decreased by 8.95% to $449.9 million in 2026.
  • The last three Assets Average figures came in at $449.9 million (Q1 2026), $494.1 million (Q4 2025), and $529.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - 33.42 Mn
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - 795.91 Mn
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - 13.04 Mn
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 1.72 Bn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 40.89 Mn
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - 26.03 Mn
7 Psyence Biomedical 241.78 Bn 241.78 Bn - 10.06 Mn
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 26.06 Bn
9 Abivax 94.26 Bn 94.26 Bn - 660.38 Mn
10 Valneva SE 167.33 Mn 44.10 Mn 5.08 Mn 449.90 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 449.90 Mn
Dec 31, 2025 494.13 Mn
Sep 30, 2025 529.50 Mn
Jun 30, 2025 521.13 Mn
Mar 31, 2025 520.80 Mn
Dec 31, 2024 550.84 Mn
Sep 30, 2024 534.90 Mn
Jun 30, 2024 524.35 Mn
Mar 31, 2024 520.63 Mn
Dec 31, 2023 530.83 Mn
Sep 30, 2023 578.74 Mn
Jun 30, 2023 612.05 Mn
Mar 31, 2023 633.60 Mn
Dec 31, 2022 668.89 Mn
Sep 30, 2022 738.79 Mn
Jun 30, 2022 823.29 Mn
Mar 31, 2022 903.94 Mn